Vasanta Putluri

4.8k total citations · 1 hit paper
45 papers, 1.6k citations indexed

About

Vasanta Putluri is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vasanta Putluri has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vasanta Putluri's work include Cancer, Hypoxia, and Metabolism (17 papers), Cancer, Lipids, and Metabolism (12 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). Vasanta Putluri is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), Cancer, Lipids, and Metabolism (12 papers) and Metabolomics and Mass Spectrometry Studies (9 papers). Vasanta Putluri collaborates with scholars based in United States, United Kingdom and Germany. Vasanta Putluri's co-authors include Nagireddy Putluri, Peter A. Calabresi, Pavan Bhargava, Adele M. Snowman, Michael D. Kornberg, Solomon H. Snyder, Paul M. Kim, Arun Sreekumar, Cristian Coarfa and Chandrashekar R. Ambati and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Vasanta Putluri

43 papers receiving 1.6k citations

Hit Papers

Dimethyl fumarate targets GAPDH and aerobic glycolysis to... 2018 2026 2020 2023 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasanta Putluri United States 21 903 470 343 239 221 45 1.6k
Chao Gu China 26 1.2k 1.3× 631 1.3× 348 1.0× 180 0.8× 234 1.1× 82 1.9k
Yi Luo China 24 895 1.0× 499 1.1× 174 0.5× 214 0.9× 273 1.2× 75 1.7k
S.M. Jamshedur Rahman United States 21 902 1.0× 375 0.8× 356 1.0× 329 1.4× 226 1.0× 32 1.6k
Ying Lu China 26 992 1.1× 564 1.2× 254 0.7× 199 0.8× 251 1.1× 81 1.9k
Qingbin Kong China 15 1.0k 1.1× 398 0.8× 191 0.6× 217 0.9× 364 1.6× 17 1.7k
Yan Ding China 20 963 1.1× 340 0.7× 206 0.6× 437 1.8× 319 1.4× 51 1.6k
Nissar Ahmad Wani India 25 887 1.0× 357 0.8× 421 1.2× 235 1.0× 586 2.7× 45 1.9k
Seon Young Nam South Korea 23 846 0.9× 329 0.7× 203 0.6× 218 0.9× 304 1.4× 62 1.5k

Countries citing papers authored by Vasanta Putluri

Since Specialization
Citations

This map shows the geographic impact of Vasanta Putluri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasanta Putluri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasanta Putluri more than expected).

Fields of papers citing papers by Vasanta Putluri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasanta Putluri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasanta Putluri. The network helps show where Vasanta Putluri may publish in the future.

Co-authorship network of co-authors of Vasanta Putluri

This figure shows the co-authorship network connecting the top 25 collaborators of Vasanta Putluri. A scholar is included among the top collaborators of Vasanta Putluri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasanta Putluri. Vasanta Putluri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Sara A., Joshua C. Anderson, Vasanta Putluri, et al.. (2025). IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity. Nature Communications. 16(1). 3874–3874. 3 indexed citations
2.
Murthy, Divya, Debasmita Dutta, Kuldeep S. Attri, et al.. (2024). CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer. Cancer Letters. 587. 216724–216724. 15 indexed citations
3.
Yazdani, Akram, Maureen Samms‐Vaughan, Sepideh Saroukhani, et al.. (2024). Metabolomic Profiles in Jamaican Children With and Without Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 55(10). 3722–3730. 1 indexed citations
4.
Park, Jun Hyoung, Sandra L. Grimm, Danthasinghe Waduge Badrajee Piyarathna, et al.. (2023). Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer. Cancer Research. 84(2). 291–304. 21 indexed citations
5.
Chakraborty, Saroj, Anju Lulla, Xi Cheng, et al.. (2023). Conjugated bile acids are nutritionally re-programmable antihypertensive metabolites. Journal of Hypertension. 41(6). 979–994. 15 indexed citations
6.
Piyarathna, Danthasinghe Waduge Badrajee, Abu Hena Mostafa Kamal, Vasanta Putluri, et al.. (2022). Lipidomic Profiling Identifies a Novel Lipid Signature Associated with Ethnicity-Specific Disparity of Bladder Cancer. Metabolites. 12(6). 544–544. 4 indexed citations
7.
Ahmed, Kazi Mokim, Ratna Veeramachaneni, Defeng Deng, et al.. (2022). Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response. Journal for ImmunoTherapy of Cancer. 10(8). e004752–e004752. 29 indexed citations
8.
Fujita, Yoko, Antonio Dono, Juan Carlos Rodrı́guez, et al.. (2022). IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas. Journal of Neuro-Oncology. 159(2). 261–270. 22 indexed citations
9.
Chu, Chun, Guodong Zhou, Vasanta Putluri, et al.. (2021). Role of Human NADPH Quinone Oxidoreductase (NQO1) in Oxygen‐Mediated Cellular Injury and Oxidative DNA Damage in Human Pulmonary Cells. Oxidative Medicine and Cellular Longevity. 2021(1). 5544600–5544600. 9 indexed citations
10.
Yu, Wangjie, Yunyun Chen, Nagireddy Putluri, et al.. (2020). Acquisition of Cisplatin Resistance Shifts Head and Neck Squamous Cell Carcinoma Metabolism toward Neutralization of Oxidative Stress. Cancers. 12(6). 1670–1670. 34 indexed citations
11.
Treviño, Lindsey S., Jianrong Dong, Tiffany A. Katz, et al.. (2020). Epigenome environment interactions accelerate epigenomic aging and unlock metabolically restricted epigenetic reprogramming in adulthood. Nature Communications. 11(1). 2316–2316. 45 indexed citations
12.
Cox, Aaron R., Natasha Chernis, David Bader, et al.. (2020). STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity. Diabetes. 69(12). 2630–2641. 28 indexed citations
13.
Jiao, Li, Suman Kumar Maity, Cristian Coarfa, et al.. (2019). A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prevention Research. 12(4). 237–246. 16 indexed citations
14.
Tang, Wei, Vasanta Putluri, Chandrashekar R. Ambati, et al.. (2019). Liver- and Microbiome-derived Bile Acids Accumulate in Human Breast Tumors and Inhibit Growth and Improve Patient Survival. Clinical Cancer Research. 25(19). 5972–5983. 44 indexed citations
15.
Suter, Melissa, Kjersti M. Aagaard, Cristian Coarfa, et al.. (2019). Association between elevated placental polycyclic aromatic hydrocarbons (PAHs) and PAH-DNA adducts from Superfund sites in Harris County, and increased risk of preterm birth (PTB). Biochemical and Biophysical Research Communications. 516(2). 344–349. 40 indexed citations
16.
Kornberg, Michael D., Pavan Bhargava, Paul M. Kim, et al.. (2018). Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science. 360(6387). 449–453. 506 indexed citations breakdown →
17.
Ballester, Leomar Y., Guangrong Lu, Soheil Zorofchian, et al.. (2018). Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors. Acta Neuropathologica Communications. 6(1). 85–85. 49 indexed citations
18.
Mishra, Prachi, Wei Tang, Vasanta Putluri, et al.. (2017). ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming. Journal of Clinical Investigation. 128(1). 323–340. 65 indexed citations
19.
Kaushik, Akash, Shaiju K. Vareed, Sumanta Basu, et al.. (2013). Metabolomic Profiling Identifies Biochemical Pathways Associated with Castration-Resistant Prostate Cancer. Journal of Proteome Research. 13(2). 1088–1100. 48 indexed citations
20.
Putluri, Nagireddy, Ali Shojaie, Vihas T. Vasu, et al.. (2011). Metabolomic Profiling Reveals a Role for Androgen in Activating Amino Acid Metabolism and Methylation in Prostate Cancer Cells. PLoS ONE. 6(7). e21417–e21417. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026